Go to the list of all blogs
Sarah Patel's Avatar
published in Blogs
May 21, 2023

Unraveling Reata Pharmaceuticals (RETA) - A Deep Dive into its -20.41% Monthly Descent

Embark on a thought-provoking exploration of Reata Pharmaceuticals (RETA) as we navigate its notable -20.41% descent, with shares plummeting to $79.98. This blog post takes you on a captivating journey through the Biotechnology Industry, shedding light on the factors that contributed to RETA's downturn. Join us as we delve into the realm of Reata Pharmaceuticals and explore the intricacies of the biotech landscape.

Understanding the Biotechnology Industry: Before delving into RETA's performance, it is crucial to grasp the broader landscape of the Biotechnology Industry. Our analysis of 959 stocks within this sector reveals that 61.23% exhibited an Uptrend, while 38.77% experienced a Downtrend. This industry overview provides a foundation for unraveling the unique challenges and opportunities faced by RETA within the highly innovative and competitive biotech arena.

Unlocking the Power of Artificial Intelligence to Make Trading Decisions with Tickeron's AI Robots.

Factors Influencing RETA's Descent: Several factors may have contributed to Reata Pharmaceuticals' -20.41% monthly descent. The biotech industry is known for its inherent risks and uncertainties, including clinical trial results, regulatory hurdles, and market dynamics. By examining these factors, we aim to uncover the intricacies that led to RETA's descent, equipping investors with valuable insights and a deeper understanding of the biotech landscape.

Navigating the Biotech Landscape: As investors evaluate the implications of RETA's descent, navigating the complex and ever-changing biotech landscape becomes crucial. Identifying promising therapeutic areas, evaluating pipeline progress, and assessing regulatory milestones are essential steps in making informed investment decisions. This blog post offers a comprehensive analysis to help investors navigate the challenges and opportunities within the dynamic biotech market.

Opportunities and Risks in Biotech: While RETA experienced a significant descent, it is important to recognize that the biotech industry presents both opportunities and risks. The pursuit of groundbreaking therapies, advancements in precision medicine, and potential market expansions offer glimpses of growth. However, investors must also be mindful of the inherent risks associated with clinical trials, regulatory uncertainties, and competitive pressures. This blog post aims to shed light on the opportunities and risks within the biotech industry, empowering investors to make informed decisions.

Reata Pharmaceuticals' -20.41% monthly descent underscores the dynamic nature of the Biotechnology Industry and the challenges faced by companies within this sector. By analyzing market trends, understanding the factors influencing RETA's performance, and identifying potential opportunities, investors can navigate the biotech market with greater confidence. It is crucial to conduct thorough research and seek advice from qualified financial professionals before making any investment decisions.

Related Ticker: RETA

RETA in upward trend: price may jump up because it broke its lower Bollinger Band on May 10, 2023

RETA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 40 cases where RETA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where RETA's RSI Indicator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 09, 2023. You may want to consider a long position or call options on RETA as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RETA just turned positive on May 26, 2023. Looking at past instances where RETA's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RETA advanced for three days, in of 278 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 205 cases where RETA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

RETA moved below its 50-day moving average on June 09, 2023 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RETA crossed bearishly below the 50-day moving average on May 18, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RETA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RETA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: RETA's P/B Ratio (400.000) is slightly higher than the industry average of (25.274). P/E Ratio (0.000) is within average values for comparable stocks, (123.513). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.391). Dividend Yield (0.000) settles around the average of (0.030) among similar stocks. RETA's P/S Ratio (2500.000) is slightly higher than the industry average of (316.785).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Sarepta Therapeutics (NASDAQ:SRPT), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Novavax (NASDAQ:NVAX), Sorrento Therapeutics (OTC:SRNEQ).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.14B. The market cap for tickers in the group ranges from 402 to 351.68B. NONOF holds the highest valuation in this group at 351.68B. The lowest valued company is PNEXF at 402.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 1%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was 34%. ONPH experienced the highest price growth at 157%, while BLPH experienced the biggest fall at -90%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -47%. For the same stocks of the Industry, the average monthly volume growth was -61% and the average quarterly volume growth was -69%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 86
Price Growth Rating: 50
SMR Rating: 93
Profit Risk Rating: 94
Seasonality Score: 7 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of pharmaceutical products for treatment of inflammatory diseases and cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
5320 Legacy Drive
Phone
+1 972 865-2219
Employees
323
Web
https://www.reatapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PP26.190.28
+1.07%
Meet Kevin Pricing Power ETF (The)
TMV119.880.63
+0.53%
Direxion Daily 20+ Yr Trsy Bear 3X ETF
XDSQ28.270.04
+0.14%
Innovator US Eq Acltd ETF™ Quarterly
PDO12.88-0.10
-0.75%
PIMCO Dynamic Income Opportunities Fund
CEFS18.24-0.17
-0.92%
Saba Closed-End Funds ETF

RETA and

Correlation & Price change

A.I.dvisor indicates that over the last year, RETA has been loosely correlated with SRPT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RETA jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RETA
1D Price
Change %
RETA100%
-0.32%
SRPT - RETA
44%
Loosely correlated
+1.40%
NTLA - RETA
41%
Loosely correlated
-0.28%
MDGL - RETA
39%
Loosely correlated
-1.36%
TSVT - RETA
36%
Loosely correlated
-0.72%
AVIR - RETA
36%
Loosely correlated
-3.75%
More
Sergey Savastiouk's Avatar
published in Blogs
Mar 14, 2023
How to Start Trading Penny Stocks

How to Start Trading Penny Stocks

Penny stocks have long been marginalized within the professional investment community, oftentimes being painted with a broad brush of simply being “too risky.” Leonardo DiCaprio’s depiction of the penny stock peddling conman, Jordan Belfort, in the Wolf of Wall Street certainly didn’t help.Here are four reasons to start trading them now. Reason #1: Let’s State the Obvious -- Penny Stocks are Cheap A single share of Apple Inc. costs over $350.
Dmitry Perepelkin's Avatar
published in Blogs
Mar 14, 2023
5 Habits that Lead to Successful Investing

5 Habits that Lead to Successful Investing

To consistently make money in this industry, you need emotional fortitude, an analytical mind, and a willingness to self-reflect. Despite trading and investing being two different activities, these principles can be applied to both.Conversely, investors with good habits often become great traders.  Rather than full sentences for titles, we’ve labeled each of our top-five investing habits using a single word principle.
Allana's Avatar
published in Blogs
Mar 23, 2023
What’s the Difference Between Data Analytics and Machine Learning?

What’s the Difference Between Data Analytics and Machine Learning?

Artificial intelligence (AI) technology is developing rapidly.Data mining can deliver raw numbers, but it does not necessarily provide actionable insights. Structure is necessary to taking abstract information and extracting commonalities, like averages, ratios, and percentages.
Sergey Savastiouk's Avatar
published in Blogs
Mar 13, 2023
4 Tips for Fast, Effective Stock Analysis

4 Tips for Fast, Effective Stock Analysis

With just a few clicks, an investor can search for individual stocks, categories of stocks, sectors, or investment themes, and then he or she can conduct a full range of technical and fundamental analysis within seconds.All powered by Artificial Intelligence.  Below, we give you 5 tips for fast, effective stock analysis using Tickeron’s Screener.
Sergey Savastiouk's Avatar
published in Blogs
Mar 20, 2023
5 Golden Principles in Investing

5 Golden Principles in Investing

You have enough faith in that stock, based on research, that the return will equal or exceed the investment.  Do unto others.The principles outlined here will ensure that happens.  Principle #1: Diversification Investors can’t be one-dimensional when constructing a portfolio.
John Jacques's Avatar
published in Blogs
Mar 24, 2023
If Hedge Funds are Using AI to Invest, Why Shouldn’t You?

If Hedge Funds are Using AI to Invest, Why Shouldn’t You?

Some of the world’s biggest financial institutions have devoted multi-million dollar budgets to developing algorithms that can find patterns in the market, identify trends, and perform automated trading designed to take advantage of even the smallest price movements. The AI revolution is so big that as it stands today, the world’s five biggest hedge funds all use systems-based approaches to trade financial markets.Indeed, quantitative trading hedge funds now manage $918 billion (according to HFR), which amounts to 30% of the $3 trillion hedge fund industry – a percentage continues to grow with each year that passes.
Sergey Savastiouk's Avatar
published in Blogs
Mar 15, 2023
The five most important Lessons Learned After 10,000 hours of Trading

The five most important Lessons Learned After 10,000 hours of Trading

Ten thousand hours of active trading, broken down into forty-hour weeks, amounts to almost five years. Having surpassed that milestone myself, I now understand why it's significant for any trader's journey. The early years taught me valuable lessons that have shaped my approach to trading. It's a misconception that great traders are born with innate talent. The truth is that it takes years of...
Edward Flores's Avatar
published in Blogs
Mar 12, 2023
What's the Difference Between Tokens and Altcoins?

What's the Difference Between Tokens and Altcoins?

Between their inherently technical nature, multiple varieties and sub-varieties, and endless terminology, cryptocurrency (defined here as digital or virtual currencies that are encrypted using cryptography, powered by the immutable digital ledger known as the blockchain) represents a whole, complex world.All altcoins possess their own blockchain, independent from their source code, that records all transactions of their native coins. Many altcoins are variants, or forks, of Bitcoin that leverage that cryptocurrency’s open-source protocol as the basis.
Edward Flores's Avatar
published in Blogs
Mar 26, 2023
Why it Pays to Invest in Dividend Stocks Over the Long Term

Why it Pays to Invest in Dividend Stocks Over the Long Term

Where smaller, more volatile companies can placate shareholders with higher returns, larger companies often use dividend payouts to entice new investors and hold their existing ones. These low-risk options may not work for every investment approach, but dividend-producing stocks can offer great benefits under the right circumstances – especially for portfolios built for the long-term.Beyond the ability to rely on these semi-regular payouts as an income stream – a strategy favored by retirees – dividends are an excellent vehicle for compounding earnings through reinvestment.
Edward Flores's Avatar
published in Blogs
Apr 02, 2023
How Artificial Intelligence Can Improve Fintech

How Artificial Intelligence Can Improve Fintech

Artificial intelligence (AI) and fintech have an inherent compatibility that has become clearer as each sector has matured, with recent growth and successes on their own accord bringing new ideas about how they can work together.AI can analyze information at far greater quantities (and far more quickly) than any human, making it a natural fit to help fintech firms streamline and automate processes that benefit customers and businesses alike. Fintech has brought a revolution of convenience to the finance world.